PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPTINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN

Details for Australian Patent Application No. 2003272270 (hide)

International Classifications

Event Publications

22 January 2004 Complete Application Filed

Priority application(s): 60/451,213 28.02.03 US; 10/378,956 03.03.03 US; 60/463,962 18.04.03 US; 60/487,064 11.07.03 US

28 October 2004 Application Open to Public Inspection

Published as AU-A-2003272270

25 August 2005 Corrigenda

Applications OPI - Name Index Under the name TRANSFORM PHARMACEUTICALS, INC., Application No. 2003272270, under INID (71) correct the name to read TRANSFORM PHARMACEUTICALS, INC.; UNIVERSITY OF SOUTH FLORIDA; THE REGENTS OF THE UNIVERSITY OF MICHIGAN

17 November 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.